Condition: Major Depressive Disorder · Inflammation · Sponsor: Universiteit Antwerpen
This is a randomised, double-blind, placebo-controlled clinical trial in which patients with major depressive disorder will receive augmentation through minocycline (MCO), celecoxib (CXB) or placebo.
This description comes directly from the study's public registry record.
Jonas Janssens, MD · 015304643 · jonas.janssens@emmaus.be
Celine Wessa, MD · Celine.wessa@emmaus.be
Always discuss trial participation with your own doctor first.
| UPC Duffel | Duffel, Antwerpen, Belgium | Recruiting |
| UZ Brussel | Brussels, Belgium | Recruiting |
| Katholiek Universiteit Leuven Campus Kortenberg | Leuven, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05644301